Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19
A.‐C. Fougerousse, M. Perrussel, Pierre‐André Bécherel, É. Bégon, V. Pallure, I. Zarâa, G. Chaby, J. Parier, M. Kemula, L. Méry‐Bossard, C. Poreaux, C. Taïeb, F. Maccari, Z. Reguiaï, the GEM Resopso
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Psoriasis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyBetacoronavirusMEDLINEIntensive care medicineCoronavirus InfectionsInternal medicineVirologyDiseaseOutbreakPolitical scienceInfectious disease (medical specialty)LawPsoriasis: Treatment and PathogenesisTherapeutic Uses of Natural ElementsFibromyalgia and Chronic Fatigue Syndrome Research